Fever Recognition Challenges in Older Adults

Abstract

Recognition of fever in older adults presents unique clinical challenges due to atypical presentations, altered thermoregulatory responses, and the presence of comorbidities. This article reviews the epidemiology, pathophysiology, risk factors, clinical features, diagnostic strategies, and management of fever in the geriatric population. By synthesizing recent evidence and guideline-based recommendations, the review aims to provide clinicians with practical insights for optimizing care in this vulnerable demographic.

Introduction

Fever remains one of the most common presenting symptoms in medical practice. However, in older adults, the recognition and interpretation of fever is complex due to age-related physiological changes and the high prevalence of chronic illnesses. Delayed or missed diagnosis of underlying infections or inflammatory processes can lead to increased morbidity and mortality in this population. Therefore, a nuanced understanding of the challenges associated with fever recognition in older adults is essential for effective clinical management.

Epidemiology / Disease Burden

The global population is aging rapidly, with individuals aged 65 and above constituting a growing proportion of healthcare users. Epidemiological data indicate that older adults frequently present to emergency departments with fever, accounting for up to 25% of all geriatric admissions. Mortality rates associated with febrile illness in this age group are substantially higher compared to younger cohorts, underscoring the seriousness of delayed or missed diagnoses. Community-acquired and healthcare-associated infections are leading causes of fever in older adults, with pneumonia, urinary tract infections, and intra-abdominal infections being most prevalent.

Pathophysiology

The pathophysiological mechanisms underlying fever in older adults are influenced by age-related changes in immune function, thermoregulation, and cytokine response. Immunosenescence leads to diminished cellular and humoral immune responses, reducing the magnitude of pyrogenic cytokine release. Additionally, changes in hypothalamic set-point sensitivity and decreased subcutaneous fat can blunt the body’s ability to mount and sustain febrile responses. Medications commonly used in the elderly, such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs), may further mask fever by altering prostaglandin synthesis and heat production.

Risk Factors

Several factors increase the risk of atypical fever presentation in older adults. These include advanced age, frailty, multiple comorbidities (e.g., diabetes, cardiovascular disease, chronic kidney disease), polypharmacy, malnutrition, and cognitive impairment. Institutionalization and the use of medical devices such as indwelling catheters further predispose to infection with blunted febrile responses. Environmental factors, including living in long-term care facilities, also contribute to the risk of both infectious and non-infectious causes of fever.

Clinical Features

Older adults often present with non-specific or atypical symptoms in the setting of fever. Classic signs, such as chills and rigors, may be absent. Instead, clinicians may encounter delirium, falls, anorexia, functional decline, or exacerbation of underlying chronic illnesses. Subtle signs such as tachypnea, confusion, or unexplained hypotension may be the initial manifestation of serious infection or sepsis. The absence of a documented temperature elevation does not exclude significant underlying pathology.

Diagnosis

Accurate diagnosis of fever in older adults requires a comprehensive approach. Standard definitions of fever (e.g., >38.0°C or 100.4°F) may not be appropriate for this population. The Infectious Diseases Society of America (IDSA) suggests considering a lower threshold for fever: an oral temperature >37.2°C (99.0°F) or persistent elevation of 1.1°C (2.0°F) above baseline. Clinical evaluation should include thorough history-taking, medication review, and focused physical examination. Laboratory investigations (CBC, CRP, procalcitonin), cultures, urinalysis, and imaging studies may be warranted based on clinical suspicion. Serial temperature monitoring and the use of core temperature measurements are preferred over peripheral methods to enhance diagnostic sensitivity.

Treatment & Management

Management of fever in older adults involves prompt identification and treatment of underlying etiologies, supportive care, and mitigation of complications. Empiric antibiotic therapy should be tailored to the most likely source of infection and local resistance patterns, with subsequent de-escalation based on culture results. Supportive measures include hydration, electrolyte balance, and management of comorbidities. Special attention should be paid to minimizing iatrogenic harm, such as avoiding unnecessary antipyretics in the absence of discomfort or hemodynamic instability. Multidisciplinary care, involving geriatricians, infectious disease specialists, and pharmacists, is recommended for complex cases.

Recent Advances / Emerging Therapies

Recent advances in the management of fever in older adults include the development of rapid diagnostic assays (e.g., multiplex PCR panels), biomarkers for early infection detection (e.g., procalcitonin, presepsin), and improved clinical decision tools. Enhanced surveillance systems in long-term care facilities aid in early outbreak identification. Research into immunomodulatory therapies and targeted antimicrobials may offer future benefits. Wearable devices capable of continuous temperature and vital sign monitoring are emerging as valuable adjuncts for early detection and intervention in high-risk populations.

Guideline Recommendations

Contemporary guidelines recommend individualized assessment of fever in older adults, emphasizing the importance of recognizing atypical presentations. The IDSA and the American Geriatrics Society advocate for lower diagnostic thresholds and the use of baseline temperature comparisons. Guidelines stress the avoidance of overtreatment with antipyretics and antibiotics, encouraging stewardship principles. Early involvement of geriatric expertise is advised for patients with complex needs or diagnostic uncertainty. Vaccination strategies, infection control measures, and education of caregivers remain cornerstones of prevention.

Conclusion

Fever recognition in older adults is fraught with challenges due to physiological, clinical, and social complexities. A high index of suspicion, judicious use of diagnostic resources, and adherence to guideline-based management are paramount. Ongoing research and the integration of novel technologies hold promise for improving outcomes. Ultimately, tailored, patient-centered approaches are essential for optimizing care and reducing the morbidity and mortality associated with febrile illnesses in the geriatric population.